Crespo RE, Jerez MD, González PM

Language: Spanish
References: 8
Page: 1-9
PDF size: 228.20 Kb.

ABSTRACT

Introduction: pyoderma gangrenosum is a rare chronic inflammatory dermatosis, which etiology and pathogenesis is still uncertain, although immunological factors and neutrophilic dysfunction seem to play an important role. In most cases, it occurs associated with non-infectious systemic disease, such as rheumatoid arthritis, hematological malignancy and inflammatory bowel disease.
Case report: a 26 year-old white female patient with a history of ulcerative colitis and eight weeks pregnant, who presented herself to the gastroenterology office at Abel Santamaria Cuadrado General Teaching Hospital, she was referred from her health area, presenting diarrhea with phlegm and blood, in addition to nodular lesions, papules and multiple vesicles with irregular edges in lower limbs, upper limbs and posterior region of the trunk, very painful.
Conclusions: the evolution of ulcerative colitis and pregnancy are correlated with the activity of the disease at the time of conception, so that the existence of an outbreak at this time has been associated with a higher risk of abortion and a worse response to medical treatment.

REFERENCES

1. Kridin K, Cohen AD, Amber KT. Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis. Am J Clin Dermatol [Internet]. 2018 [citado 31/07/2019]: 479-487. Disponible en: Disponible en: https://link.springer.com/article/10.1007/s40257-018-0356-7

2. Osterman M.T, Lichtenstein G.R .Ulcerative colitis. Extraintestinal manifestations. Small and Large intestine In: Sleisenger and Fordtran’s Gastrointestinal and Liver diseases.10th ed. Philadelphia: Elsevier Saunders; 2016: 2058-61. https://www.elsevier.com/books/sleisenger-and-fordtrans-gastrointestinal-and-liver-disease-2-volume-set/feldman/978-1-4557-4692-7

3. Vallini V, Andreini R, Bonadio A. Pyoderma Gangrenosum: A Current Problem as Much as an Unknown One. Sage journals [Internet].2017[citado 31/07/2019]; 6(3): 191-201. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/28915774/

4. Alavi A, French LE, Davis MD, Brassard A, Kirsner , RS. Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment. Am J Clin Dermatol [Internet].2017 [citado 31/07/2019]; 18(3): 355-72. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/28224502/

5. Yasin F, Assad S, Zahid M, Malik SA. Extensive Pyoderma Gangrenosum: A Challenging Diagnosis and Literature Review of Management. Cureus [Internet].2017 [citado 31/07/2019]; 9(7): e1486. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/28944125/

6. Soto Vilches F, Vera-Kellet C. Pioderma gangrenoso: terapias clásicas y emergentes. Med Clin (Barc)[Internet]. 2017 [citado 2019 jul 31]; 149(6): 256-260. Disponible en: Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0025775317303433

7. Chatzinasiou F, Polymeros D, Panagiotou M, Theodoro-poulos K, Rigopoulos D. Generalized pioderma gangrenosoum associated with ulcerative colitis: succesful treatment with infliximab and azathioprine, Acta Dermatovenerol Croat [Internet]. 2016 [citado 31/07/2019]; 24(1): 83-5. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/27149138/

8. Quist SR, Kraas L. Treatment options for pyoderma gangrenosum. JDDG [Internet]. 2017 [citado 31/07/2019]; 15: 34-40. Disponible en: Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1111/ddg.13173